Search | IOVS | ARVO Journals

View

Showing 1 – 7 of 7

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

Diabetes mellitus in MacTel Can Diabetes Mellitus be a negative prognosticator in MacTel?

Daniela Florea; Tatiana Mansour; Traci Clemons; Konstantinos Balaskas; Catherine Egan; Tunde Peto

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1034. doi:

ARVO Annual Meeting Abstract June 2017

Progression of Ellipsoid Zone Loss correlates with Change of Scotoma Size in Macular Telangiectasia Type 2.

Tjebo FC Heeren; Diána Kitka; Daniela Florea; Alan C Bird; Emily Chew; Traci E Clemons; Daniel Pauleikhoff; Frank G Holz; Tunde Peto

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1280. doi:

ARVO Annual Meeting Abstract April 2014

Comparison of two microperimetry tests in a clincial trial for Macular Telangiectasia Type 2

Tunde Peto; Stela Vujosevic; Ferenc B Sallo; Daniela Florea; Irene Leung; Traci E Clemons; Emily Y Chew; Alan C Bird; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):674. doi:

ARVO Annual Meeting Abstract April 2014

Enhanced peripheral grading categories for ultra-wide field imaging in the Reykjavik Eye Study

Daniela Ioana Florea; Imre Lengyel; Fridbert Jonasson; Tunde Peto

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):660. doi:

ARVO Annual Meeting Abstract April 2014

Feasibility of microperimetry testing at multiple sites in type 2 idiopathic macular telangiectasia

Stela Vujosevic; Ferenc B Sallo; Irene leung; Daniela Ioana Florea; Daniel Pauleikhoff; Traci E Clemons; Alan C Bird; Tunde Peto; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5013. doi:

ARVO Annual Meeting Abstract June 2013

Comparison of main OCT features of Type 2 macular telangiectasia in time- and spectral domain OCTs

Tunde Peto; Irene Leung; Ferenc Sallo; Daniela Florea; Alan Bird; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3604. doi:

ARVO Annual Meeting Abstract June 2013

Subretinal neovascularisation in Macular Telangiectasia type 2: Baseline characteristics and progression over two years

Konstantinos Balaskas; Ferenc Sallo; Irene Leung; Daniela Florea; Alan Bird; Tunde Peto; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1563. doi:

Advertisement